{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T21:44:22Z","timestamp":1788212662675,"version":"build-2803163510"},"reference-count":14,"publisher":"Society for Clinical Epidemiology","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["ACE","Ann Clin Epidemiol"],"published-print":{"date-parts":[[2023]]},"DOI":"10.37737\/ace.23001","type":"journal-article","created":{"date-parts":[[2023,1,10]],"date-time":"2023-01-10T22:10:19Z","timestamp":1673388619000},"page":"1-4","source":"Crossref","is-referenced-by-count":5,"title":["Current status of health technology assessment research in Japan"],"prefix":"10.37737","volume":"5","author":[{"given":"Takaaki","family":"Konishi","sequence":"first","affiliation":[{"name":"Department of Breast and Endocrine Surgery, Graduate School of Medicine, The University of Tokyo"},{"name":"Department of Clinical Epidemiology and Health Economics, School of Public Health, The University of Tokyo"},{"name":"Science, Technology, and Innovation Governance Education and Research Program, Graduate School of Public Policy, The University of Tokyo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideo","family":"Yasunaga","sequence":"additional","affiliation":[{"name":"Department of Clinical Epidemiology and Health Economics, School of Public Health, The University of Tokyo"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"24670","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1. Hofmann S, Branner J, Misra A, Lintener H. A review of current approaches to defining and valuing innovation in health technology assessment. Value Health 2021;24:1773\u20131783. doi:10.1016\/j.jval.2021.06.006","DOI":"10.1016\/j.jval.2021.06.006"},{"key":"2","doi-asserted-by":"publisher","unstructured":"2. Panteli D, Eckhardt H, Nolting A, Busse R, Kulig M. From market access to patient access: overview of evidence-based approaches for the reimbursement and pricing of pharmaceuticals in 36 European countries. Health Res Policy Sys 2015;13:39. doi:10.1186\/s12961-015-0028-5","DOI":"10.1186\/s12961-015-0028-5"},{"key":"3","doi-asserted-by":"publisher","unstructured":"3. O\u2019Rourke B, Oortwijn W, Schuller T, International Joint Task Group. The new definition of health technology assessment: A milestone in international collaboration. Int J Technol Assess Health Care 2020;36:187\u2013190. doi:10.1017\/S0266462320000215","DOI":"10.1017\/S0266462320000215"},{"key":"4","doi-asserted-by":"publisher","unstructured":"4. Raftery J, Powell J. Health technology assessment in the UK. Lancet 2013;382:1278\u20131285. doi:10.1016\/S0140-6736(13)61724-9","DOI":"10.1016\/S0140-6736(13)61724-9"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Shiroiwa T. Development of an official guideline for the economic evaluation of drugs\/medical devices in Japan. Value Health Published online 2017;20:372\u2013378.","DOI":"10.1016\/j.jval.2016.08.726"},{"key":"6","unstructured":"6. Center for Outcomes Research and Economic Evaluation for Health, National Institute of Public Health. Guideline for preparing cost-effectiveness evaluation to the central social insurance medical council. Accessed September 28, 2022. https:\/\/c2h.niph.go.jp\/tools\/guideline\/guideline_en.pdf"},{"key":"7","doi-asserted-by":"publisher","unstructured":"7. Chalkidou K, Marten R, Cutler D, Culyer T, Smith R, Teerawattananon Y, et al. Health technology assessment in universal health coverage. Lancet 2013;382:e48\u2013e49. doi:10.1016\/S0140-6736(13)62559-3","DOI":"10.1016\/S0140-6736(13)62559-3"},{"key":"8","doi-asserted-by":"publisher","unstructured":"8. Briggs A, Sculpher M. An introduction to Markov modelling for economic evaluation. Pharmacoeconomics 1998;13:397\u2013409. doi:10.2165\/00019053-199813040-00003","DOI":"10.2165\/00019053-199813040-00003"},{"key":"9","doi-asserted-by":"publisher","unstructured":"9. Woods BS, Sideris E, Palmer S, Latimer N, Soares M. Partitioned survival and state transition models for healthcare decision making in oncology: Where are we now? Value Health 2020;23:1613\u20131621. doi:10.1016\/j.jval.2020.08.2094","DOI":"10.1016\/j.jval.2020.08.2094"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Gaglio B, Henton M, Barbeau A, Barbeau A, Evans E, Hickam D, et al. Methodological standards for qualitative and mixed methods patient centered outcomes research. BMJ 2020;371:m4435. doi:10.1136\/bmj.m4435","DOI":"10.1136\/bmj.m4435"},{"key":"11","doi-asserted-by":"publisher","unstructured":"11. Chen Y, He Y, Chi X, Wei Y, Shi L. Development of health technology assessment in China: New challenges. BST 2018;12:102\u2013108. doi:10.5582\/bst.2018.01038","DOI":"10.5582\/bst.2018.01038"},{"key":"12","doi-asserted-by":"publisher","unstructured":"12. Shiroiwa T. Cost-effectiveness evaluation for pricing medicines and devices: A new value-based price adjustment system in Japan. Int J Technol Assess Health Care 2020;36:270\u2013276. doi:10.1017\/S0266462320000264","DOI":"10.1017\/S0266462320000264"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Organisation for Economic Co-operation and Development [OECD]. Life expectancy at birth (indicator). Accessed November 4, 2022. doi:10.1787\/27e0fc9d-en","DOI":"10.1787\/27e0fc9d-en"},{"key":"14","doi-asserted-by":"publisher","unstructured":"14. Suguimoto SP, Techasrivichien T, Musumari PM, El-saaidi C, Lukhele BW, Ono-Kihara M, Kihara M. Changing patterns of HIV epidemic in 30 years in East Asia. Curr HIV\/AIDS Rep 2014;11:134\u2013145. doi:10.1007\/s11904-014-0201-4","DOI":"10.1007\/s11904-014-0201-4"}],"container-title":["Annals of Clinical Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ace\/5\/1\/5_23001\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T05:20:12Z","timestamp":1715318412000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ace\/5\/1\/5_23001\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.37737\/ace.23001","relation":{},"ISSN":["2434-4338"],"issn-type":[{"value":"2434-4338","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023]]},"article-number":"23001"}}